Kim Branson, GSK's head of AI and machine learning
GSK expands AI partnership with Tempus, fronting $70M for access to 'multimodal data'
GSK has been aggressively looking at AI, and in its newest venture, the Big Pharma has expanded a deal with an old partner in a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
